The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth
Data up to Jan 2025
Total Citations Per Year
Abstract
References (22)
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
1992 • 2,084 citations
A potent specific pure antiestrogen with clinical potential.
1991 • 1,111 citations
Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration.
1988 • 417 citations
Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
1985 • 396 citations
Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.
1989 • 249 citations
Acquired Tamoxifen Resistance: Correlation With Reduced Breast Tumor Levels of Tamoxifen and Isomerization of Trans-4-Hydroxytamoxifen
1991 • 233 citations
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen
1993 • 195 citations
Human breast cancer in the athymic nude mouse: Cystostatic effects of long-term antiestrogen therapy
1987 • 186 citations
Tamoxifen
1989 • 170 citations
Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen
1982 • 169 citations
Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients.
1992 • 144 citations
Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer.
1993 • 113 citations
Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells
1989 • 110 citations
Investigation of the Mechanism of Tamoxifen-Stimulated Breast Tumor Growth With Nonisomerizable Analogues of Tamoxifen and Metabolites
1993 • 92 citations
Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors.
1992 • 87 citations
Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.
1990 • 82 citations
Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells
1989 • 66 citations
Synthesis and estrogen receptor binding of 6,7-dihydro-8-phenyl-9-[4-[2-(dimethylamino)ethoxy]phenyl]-5H-benzocycloheptene, a nonisomerizable analog of tamoxifen. X-ray crystallographic studies
1986 • 50 citations
CURRENT CLINICAL ONCOLOGY
2003 • 44 citations
Nafoxidine–-an antiestrogen for the treatment of breast cancer
1976 • 43 citations
Nonisomerizable analogs of (Z)- and (E)-4-hydroxytamoxifen. Synthesis and endocrinological properties of substituted diphenylbenzocycloheptenes
1988 • 34 citations
Hormonal Treatment of Advanced Breast Cancer
1995 • 34 citations
Cited By (0)
No citing papers found in database